SCHEMBL17464243

SCHEMBL17464243

CSCC[C@H](NC(=O)OC(C)(C)C)C(=O)OCc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK7 P49862 1/20 0.65
KLK5 Q9Y337 1/20 0.57
CTSS P25774 3/20 0.54
CTSK P43235 2/20 0.54
PPARA Q07869 3/20 0.54
POLB P06746 1/20 0.53
MME P08473 1/20 0.53
ANPEP P15144 1/20 0.53
EPHX2 P34913 1/20 0.52
MEN1 O00255 1/20 0.52
ALDH1A1 P00352 1/20 0.52
LMNA P02545 1/20 0.52
TSHR P16473 1/20 0.52
KMT2A Q03164 1/20 0.52
HSD17B10 Q99714 1/20 0.52
PPARG P37231 2/20 0.51
SYK P43405 1/20 0.51
CA2 P00918 1/20 0.50
CA1 P00915 1/20 0.50
BACE1 P56817 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12873043 1.00 KLK7 (0.65) KLK7KLK5CTSSCTSKPPARA
SCHEMBL11682562 0.93 MME (0.59) KLK7KLK5CTSSCTSKMME
SCHEMBL4704430 0.90 KLK7 (0.55) KLK7KLK5CTSSCTSKPPARA
SCHEMBL7304843 0.89 KLK7 (0.54) KLK7KLK5CTSSCTSKPPARA
SCHEMBL11605396 0.89 CTSS (0.56) KLK7KLK5CTSSCTSKPPARA
SCHEMBL11606668 0.89 CTSS (0.56) KLK7KLK5CTSSCTSKPPARA
SCHEMBL14271199 0.89 PPARA (0.57) KLK7KLK5CTSSCTSKPPARA
SCHEMBL6619713 0.89 KLK7 (0.58) KLK7KLK5CTSSCTSKPPARA
SCHEMBL6619716 0.89 KLK7 (0.58) KLK7KLK5CTSSCTSKPPARA
SCHEMBL30788980 0.88 CTSK (0.54) KLK7KLK5CTSSCTSKPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160024143-A1 DEPROTECTION METHOD AJINOMOTO CO., INC. (JP) 2016-01-28 US disclosed
US-20160024143-A1 DEPROTECTION METHOD AJINOMOTO CO., INC. (JP) 2016-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024143-A1 DEPROTECTION METHOD CBR1, AOX1, AOC2 KLK7 3354/4885KLK5 2772/4885CTSS 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.